Hankang Capital key facts
- Hankang Capital is a venture capital firm based in Shanghai, China with 22 tracked portfolio companies.
- Notable positions include CuroVax, Zenshine Pharmaceuticals (Nanjing) Group, Highlightll Pharma.
About Hankang Capital
Founded in 2010, Hankang Capital is a corporate venture capital firm of Zhongjianxin Group headquartered in Shanghai, China. The firm focuses on making investments in sectors like biomedicine, medical equipment, diagnostic reagents, medical services and other major health fields.
Hankang Capital portfolio at a glance
22 portfolio companies are on record for Hankang Capital, including CuroVax, Zenshine Pharmaceuticals (Nanjing) Group and Highlightll Pharma.
6 of the 22 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·The top 10 names in the book — of 22 recorded positions
- ·Watchlist + alerts for Hankang Capital's activity
Portfolio
22 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| CuroVax | — | ▮ | ▮ | ▮ |
| Zenshine Pharmaceuticals (Nanjing) Group | — | ▮ | ▮ | ▮ |
| Highlightll Pharma | — | ▮ | ▮ | ▮ |
+ 19 more companies · all 22, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about Hankang Capital
- What companies does Hankang Capital invest in?
- Hankang Capital has 22 recorded portfolio companies, including CuroVax, Zenshine Pharmaceuticals (Nanjing) Group, Highlightll Pharma.
- What is Hankang Capital's AUM?
- Hankang Capital manages approximately $280.9M in assets.